Incyte strikes up to $2 billion deal for Star Therapeutics' subsidiary
Incyte Corporation
Incyte Corporation INCY | 0.00 |
June 8 (Reuters) - Incyte INCY said on Monday it has agreed to acquire Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics, in a deal worth up to $2 billion, expanding its pipeline for blood disorder therapies.